Skip to main content
ANAB
NASDAQ Life Sciences

AnaptysBio Completes Spin-Off, Transfers $100M to First Tracks in Separation Deal

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$51.2
Mkt Cap
$1.465B
52W Low
$11.402
52W High
$51.43
52W Position info
349% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

AnaptysBio has completed the spin-off of First Tracks Biotherapeutics, formalizing the separation with key agreements. The Separation and Distribution Agreement includes a material $100 million cash transfer to First Tracks and outlines asset/liability division, tax sharing, and IP licensing. Additionally, a two-year Transition Services Agreement will ensure operational continuity. This event follows the company's earlier approval of the spin-off (March 27 8-K) and a recent news report (20 minutes prior) noting its successful completion and a subsequent 11% stock surge. The detailed terms of the separation, particularly the significant cash transfer, are new and crucial for understanding AnaptysBio's post-spin-off financial structure and strategic focus. Investors will now monitor the independent performance of both companies.

At the time of this announcement, ANAB was trading at $51.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $51.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.25 info
Change: -$1.52 (-3%) info
Market Cap: $1.383B info
ANAB
Nov 12, 2026, 4:16 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.25 info
Change: -$1.52 (-3%) info
Market Cap: $1.383B info
ANAB
Oct 20, 2026, 3:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $46.25 info
Change: +$1.25 (+3%) info
Market Cap: $1.383B info
ANAB
Oct 19, 2026, 2:18 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $49.23
Real-time Price: $46.25 info
Change: -$2.98 (-6%) info
Market Cap: $1.383B info
ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $46.25 info
Change: -$4.60 (-9%) info
Market Cap: $1.383B info